
Cancer therapy gets two-factor authentication
Status
Founded
Development stage
Switch Biologics is unlocking the power of enzymes for solid tumours. It's solved the delivery problem that highly potent yet toxic enzymes pose for systemic use with a proprietary Logic-Gated Platform that acts as a safety lock. Its payload remains inert until triggered by two specific tumour signals, confining catalytic power to the cancer site. By combining the potency of cell therapy with the scalability of a biologic, Switch Biologics offers a cost-effective solution for patients with few remaining options.